Key result
Higher levels of nonsomatic depression symptoms predicted increased mortality risk in early-stage chronic kidney disease (p=0.005), with a 21.4% higher mortality rate for scores 1 SD above the mean.
Why the study?
Do higher levels of nonsomatic depression symptoms increase mortality risk in patients with early-stage chronic kidney disease?
Population
359 patients in the early stages of chronic kidney disease before initiation of renal replacement therapy
Comparison
Higher levels of nonsomatic depression symptoms vs Lower levels of nonsomatic depression symptoms
Design
Cohort
Follow-up
average 81 months
Authors
Loading...
Nonsomatic depressive symptoms were associated with higher mortality in early CKD; leaves open whether screening or treatment improves outcomes.
Cohort (n=359)
Do higher levels of nonsomatic depression symptoms increase mortality risk in patients with early-stage chronic kidney disease?
p-value: p=.005
Higher levels of nonsomatic depressive symptoms independently predict increased mortality risk in patients with early-stage chronic kidney disease.
Kellerman et al. (2010) conducted a cohort in Chronic kidney disease (n=359). Nonsomatic depression symptoms vs. Average or lower depression scores was evaluated on Mortality status (p=.005). Higher levels of nonsomatic depression symptoms predicted increased mortality risk in early-stage chronic kidney disease (p=0.005), with a 21.4% higher mortality rate for scores 1 SD above the mean.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: